Pernicious Anemia Associated with Interferon-α Therapy and Chronic Hepatitis C Infection [3]

Journal of Clinical Gastroenterology

Volumn 38, Issue 4, 2004, Pages 382-

  Andrès, Emmanuel ^a   Loukili, Noureddine Henoun ^a   Ben Abdelghani, Maher ^a   Noel, Esther ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYANOCOBALAMIN;

ADULT; AGED; CASE REPORT; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; FEMALE; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; MALE; PATHOGENESIS; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; TREATMENT OUTCOME;

EID: 1642336889     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200404000-00018     Document Type: Letter

References (5)

1. Willson RA. Interferon alfa-induced pernicious anemia in chronic hepatitis C infection. J Clin Gastroenterol. 2001;33:426-427.
2. Borgia G, Reynaud L, Gentile I, et al. Pernicious anemia during interferon-alpha treatment for chronic hepatitis C. J Interferon Cytokine Res. 2003;23:11-12.
3. Andrès E, Loukili NH, Noel E, et al. La maladie de Biermer en médecine interne. Données actuelles issues d'une étude rétrospective multicentrique de 49 patients. Rev Med Interne. 2003; in press.
4. Cacoub P, Renou C, Rosenthal E, et al. Extra-hepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore). 2000;79: 47-56.
5. Andrés E, Maloisel F, Grunenberger F, et al. Interféron α et auto-immunité: résultats préliminaires d'une étude prospective de 60 patients. Rev Med Interne. 2002;23:37S.